These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15177052)

  • 1. The pharmacogenomics of Alzheimer's disease.
    Crentsil V
    Ageing Res Rev; 2004 Apr; 3(2):153-69. PubMed ID: 15177052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics in Alzheimer's disease.
    Cacabelos R
    Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of pharmacogenetic factors on Alzheimer's disease therapeutics.
    Cacabelos R
    Neurodegener Dis; 2008; 5(3-4):176-8. PubMed ID: 18322383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of pro-inflammatory genes and Alzheimer's disease risk: a pharmacogenomic approach.
    Candore G; Balistreri CR; Grimaldi MP; Listì F; Vasto S; Chiappelli M; Licastro F; Colonna-Romano G; Lio D; Caruso C
    Mech Ageing Dev; 2007 Jan; 128(1):67-75. PubMed ID: 17116319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics and therapeutic strategies for dementia.
    Cacabelos R
    Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rethinking Alzheimer's disease therapy: are mitochondria the key?
    Ankarcrona M; Mangialasche F; Winblad B
    J Alzheimers Dis; 2010; 20 Suppl 2():S579-90. PubMed ID: 20463405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traumatic brain injury and Alzheimer's disease: a review.
    Van Den Heuvel C; Thornton E; Vink R
    Prog Brain Res; 2007; 161():303-16. PubMed ID: 17618986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are mitochondria critical in the pathogenesis of Alzheimer's disease?
    Reddy PH; Beal MF
    Brain Res Brain Res Rev; 2005 Nov; 49(3):618-32. PubMed ID: 16269322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin.
    Ray B; Lahiri DK
    Curr Opin Pharmacol; 2009 Aug; 9(4):434-44. PubMed ID: 19656726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
    Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
    Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects.
    Sleegers K; Lambert JC; Bertram L; Cruts M; Amouyel P; Van Broeckhoven C
    Trends Genet; 2010 Feb; 26(2):84-93. PubMed ID: 20080314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk and protective factors for sporadic Alzheimer's disease.
    Stozická Z; Zilka N; Novák M
    Acta Virol; 2007; 51(4):205-22. PubMed ID: 18197729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanded high-resolution genetic study of 109 Swedish families with Alzheimer's disease.
    Sillén A; Andrade J; Lilius L; Forsell C; Axelman K; Odeberg J; Winblad B; Graff C
    Eur J Hum Genet; 2008 Feb; 16(2):202-8. PubMed ID: 17957224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of Alzheimer's disease: an update.
    Brouwers N; Sleegers K; Van Broeckhoven C
    Ann Med; 2008; 40(8):562-83. PubMed ID: 18608129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease.
    Choi SH; Kim SY; Na HR; Kim BK; Yang DW; Kwon JC; Park MY
    Dement Geriatr Cogn Disord; 2008; 25(5):445-50. PubMed ID: 18401173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic options in Alzheimer's disease.
    Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G
    Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium may be useful in the prevention of Alzheimer's disease in individuals at risk of presenile familial Alzheimer's disease.
    Yeh HL; Tsai SJ
    Med Hypotheses; 2008 Dec; 71(6):948-51. PubMed ID: 18760542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.